TAK
Takeda Pharmaceutical Company Limited
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · JP
$21.06
+1.49%Margins
Gross margin
59.4%
EBITDA margin
28.0%
EBIT margin
13.7%
Net margin
8.2%
FCF margin
9.5%
5.2%
Return on equity
2.5%
Return on assets
5.4%
Return on invested capital
0.31x
Asset turnover
$5.2B
Cash from operations
$0.89
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026